O3 Heme-arginate as a latency-reversing agent for HIV-1 cure
Michaela Madlenakova +6 more
openaire +2 more sources
Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity. [PDF]
Martin AR +5 more
europepmc +1 more source
Epigenetic regulation of HIV-1 transcription: insights into latency mechanisms and therapeutic strategies. [PDF]
Yang S, Yuan J, Sun X, Huan C.
europepmc +1 more source
Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems. [PDF]
Bialek JK +7 more
europepmc +1 more source
BRD proteins in human retroviral infection: emerging evidence from HIV-1 and future perspectives for HTLV-1. [PDF]
Akbarin MM, Farjami Z, Álvarez HR.
europepmc +1 more source
<i>Euphorbia kansui</i> for latent virus reactivation in people living with HIV on suppressive antiretroviral therapy: A phase 1b/2a clinical trial. [PDF]
Xun J +23 more
europepmc +1 more source
Selection of effective LRAs using a newly designed <i>in vitro</i> HIV latency reactivation protocol: toward future application in HIV samples. [PDF]
Neri A +14 more
europepmc +1 more source
Targeting NF-κB signaling for HIV latency reversal: Mechanisms, challenges, and therapeutic perspectives. [PDF]
Shirazi MMA, Sadat SM.
europepmc +1 more source
Kinetics of HIV-1 Latency Reversal Quantified on the Single-Cell Level Using a Novel Flow-Based Technique. [PDF]
Martrus G +7 more
europepmc +1 more source
Immune checkpoint inhibitors in HIV infection: current evidence on viral reservoir regulation and immune restoration. [PDF]
Wang Y +5 more
europepmc +1 more source

